These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28892144)

  • 21. [Drug Development Based on Intracellular Pharmacokinetic Analysis of Molecular Target Drug in Mice Bearing Patient-derived Xenograft Model].
    Hamada A
    Yakugaku Zasshi; 2020; 140(5):641-648. PubMed ID: 32378664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-Derived Xenografts of Breast Cancer.
    Varešlija D; Cocchiglia S; Byrne C; Young L
    Methods Mol Biol; 2017; 1501():327-336. PubMed ID: 27796962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncology.
    Rosfjord E; Lucas J; Li G; Gerber HP
    Biochem Pharmacol; 2014 Sep; 91(2):135-43. PubMed ID: 24950467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Knowledge and practice of patient-derived xenograft models in leukemia].
    Kato I
    Rinsho Ketsueki; 2022; 63(9):1335-1343. PubMed ID: 36198560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse models in oncoimmunology.
    Zitvogel L; Pitt JM; Daillère R; Smyth MJ; Kroemer G
    Nat Rev Cancer; 2016 Dec; 16(12):759-773. PubMed ID: 27687979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery.
    Cacciapuoti MT; Cappelli LV; Fiore D; Toruno P; Kayembe C; Tam W; Inghirami G
    Curr Protoc; 2021 Apr; 1(4):e96. PubMed ID: 33861502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research.
    Li Z; Yang X; Zhang Y; Yang X; Cui X; Zhang Y; Gong W; Bai H; Liu N; Tang Z; Guo M; Li K; Zhang T; Wang L; Song X
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal models for modeling pancreatic cancer and novel drug discovery.
    Bisht S; Feldmann G
    Expert Opin Drug Discov; 2019 Feb; 14(2):127-142. PubMed ID: 30657339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies.
    Bagby S; Messersmith WA; Pitts TM; Capasso A; Varella-Garcia M; Klauck PJ; Kim J; Tan AC; Eckhardt SG; Tentler JJ; Arcaroli J
    J Vis Exp; 2016 Sep; (115):. PubMed ID: 27768028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer.
    Wang Y; Cui J; Wang L
    Chin Clin Oncol; 2019 Apr; 8(2):17. PubMed ID: 30943729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
    Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
    Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy.
    Wege AK
    BioDrugs; 2018 Jun; 32(3):245-266. PubMed ID: 29589229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor].
    Wang Z; Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice.
    Martínez-Sabadell A; Ovejero Romero P; Arribas J; Arenas EJ
    STAR Protoc; 2022 Dec; 3(4):101712. PubMed ID: 36317178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models.
    Pyo KH; Kim JH; Lee JM; Kim SE; Cho JS; Lim SM; Cho BC
    Lung Cancer; 2019 Jan; 127():112-121. PubMed ID: 30642538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-derived xenografts as in vivo models for research in urological malignancies.
    Inoue T; Terada N; Kobayashi T; Ogawa O
    Nat Rev Urol; 2017 May; 14(5):267-283. PubMed ID: 28248952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents.
    Morillon YM; Sabzevari A; Schlom J; Greiner JW
    Anticancer Res; 2020 Oct; 40(10):5329-5341. PubMed ID: 32988851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
    Jung J; Seol HS; Chang S
    Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The design, analysis and application of mouse clinical trials in oncology drug development.
    Guo S; Jiang X; Mao B; Li QX
    BMC Cancer; 2019 Jul; 19(1):718. PubMed ID: 31331301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The future of patient-derived tumor xenografts in cancer treatment.
    Sia D; Moeini A; Labgaa I; Villanueva A
    Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.